A Review of Adjustable Continence Devices for the Treatment of Stress Urinary Incontinence with Neurogenic Etiology

Midurethral slings may lose their effectiveness due to changes in urethral compression over time in patients with urinary incontinence due to intrinsic sphincter deficiency and neurogenic bladder. Adjustable continence devices offer potential solutions. We reviewed the current literature regarding six adjustable continence devices for male and female patients suffering from incontinence. We reviewed the following devices: Adjustable Continence Therapy^® (Uromedica, Irvine, CA), Pro-Adjustable Continence Therapy^® for men (Uromedica, Irvine, CA), TRT Remeex (Neomedic, Barcelona, Spain) for females, MRS II Remeex (Neomedic, Barelona, Spain) for men, Argus ^®, and Phorbas^® adjustable continence therapy for men (Promedon SA, Cordoba, Argentina). Based on the reviewed studies, adjustable continence devices offer similar, if not less, risk than traditional stress urinary incontinence (SUI) procedures with greater outcomes as reported by patients. Adjustable continence devices allow clinicians to adjust urethral tension post-operatively if necessary without secondary procedures and general anesthesia. Adjustable devices are particularly well-suited to SUI with a neurogenic etiology as these devices allow for post-operative adjustments to sphincter pressure from a clinical setting.